{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:21:33Z","timestamp":1773130893949,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is known as an immune inhibitory receptor that is expressed on activated effector T cells and regulatory T cells. When CTLA-4 binds to CD80 or CD86, immunoinhibitory signals are transmitted to retain a homeostasis of the immune response. Recent studies have reported that CTLA-4 is upregulated in chronic infections and malignant neoplasms, contributing to host immune dysfunction. On the other hand, the blockade of CTLA-4 and CD80 or CD86 binding by antibody restores the immune response against these diseases. In a previous report, we indicated that the expression of CTLA-4 was closely associated with disease progression in cattle infected with the bovine leukemia virus (BLV). In this study, we established an anti-bovine CTLA-4 antibody to confirm its immune enhancing effect.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Bovine CTLA-4-Ig binds to bovine CD80 and CD86 expressing cells. Additionally, CD80 and CD86 bind to CTLA-4 expressing cells in an expression-dependent manner. Bovine CTLA-4-Ig significantly inhibited interferon-gamma (IFN-\u03b3) production from bovine peripheral blood mononuclear cells (PBMCs) activated by Staphylococcus enterotoxin B (SEB). An established specific monoclonal antibody (mAb) for bovine CTLA-4 specifically recognized only with bovine CTLA-4, not CD28, and the antibody blocked the binding of CTLA-4-Ig to both CD80 and CD86 in a dose-dependent manner. The bovine CTLA-4 mAb significantly restored the inhibited IFN-\u03b3 production from the CTLA-4-Ig treated PBMCs. In addition, the CTLA-4 mAb significantly enhanced IFN-\u03b3 production from CTLA-4 expressing PBMCs activated by SEB. Finally, we examined whether a CTLA-4 blockade by CTLA-4 mAb could restore the immune reaction during chronic infection; the blockade assay was performed using PBMCs from BLV-infected cattle. The CTLA-4 blockade enhanced IFN-\u03b3 production from the PBMCs in response to BLV-antigens.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Collectively, these results suggest that anti-bovine CTLA-4 antibody can reactivate lymphocyte functions and could be applied for a new therapy against refractory chronic diseases. Further investigation is required for future clinical applications.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12917-019-2082-7","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T20:44:07Z","timestamp":1572468247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Immune inhibitory function of bovine CTLA-4 and the effects of its blockade in IFN-\u03b3 production"],"prefix":"10.1186","volume":"15","author":[{"given":"Kei","family":"Watari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3230-7109","authenticated-orcid":false,"given":"Satoru","family":"Konnai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Okagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,29]]},"reference":[{"key":"2082_CR1","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature01621","volume":"423","author":"H Ueda","year":"2003","unstructured":"Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, R\u00f8nningen KS, Guja C, Ionescu-T\u00eergovi\u015fte C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003;423:506\u201311.","journal-title":"Nature"},{"key":"2082_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S1074-7613(04)00110-4","volume":"20","author":"L Vijayakrishnan","year":"2004","unstructured":"Vijayakrishnan L, Slavik JM, Ill\u00e9s Z, Greenwald RJ, Rainbow D, Greve B, Peterson LB, Hafler DA, Freeman GJ, Sharpe AH, Wicker LS, Kuchroo VK. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity. 2004;20:563\u201375.","journal-title":"Immunity"},{"key":"2082_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1440-1797.2007.00921.x","volume":"13","author":"WR Mulley","year":"2008","unstructured":"Mulley WR, Nikolic-Paterson DJ. Indoleamine 2,3-dioxygenase in transplantation. Nephrology. 2008;13:204\u201311.","journal-title":"Nephrology"},{"key":"2082_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.it.2011.06.002","volume":"32","author":"K Wing","year":"2011","unstructured":"Wing K, Yamaguchi T, Sakaguchi S. Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation. Trends Immunol. 2011;32:428\u201333.","journal-title":"Trends Immunol"},{"key":"2082_CR5","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/ni1515","volume":"11","author":"DE Kaufmann","year":"2007","unstructured":"Kaufmann DE, Kavanagh DG, Pereyra F, Zaunders JJ, Mackey EW, Miura T, Palmer S, Brockman M, Rathod A, Piechocka-Trocha A, Baker B, Zhu B, Le Gall S, Waring MT, Ahern R, Moss K, Kelleher AD, Coffin JM, Freeman GJ, Rosenberg ES, Walker BD. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol. 2007;11:1246\u201354.","journal-title":"Nat Immunol"},{"key":"2082_CR6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1348-0421.2010.00259.x","volume":"54","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Jiang Y, Zhang M, Liu J, Sun G, Shi W, Wang Y, Shang H. Alterations of CD4+CD25+Foxp3+ regulatory T cells in HIV-infected slow progressors of former blood donors in China. Microbiol Immunol. 2010;54:625\u201333.","journal-title":"Microbiol Immunol"},{"key":"2082_CR7","doi-asserted-by":"publisher","first-page":"e1000313","DOI":"10.1371\/journal.ppat.1000313","volume":"5","author":"N Nakamoto","year":"2009","unstructured":"Nakamoto N, Cho H, Shaked A, Olthoff K, Valiga ME, Kaminski M, Gostick E, Price DA, Freeman GJ, Wherry EJ, Chang KM. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade. PLoS Pathog. 2009;5:e1000313.","journal-title":"PLoS Pathog"},{"key":"2082_CR8","doi-asserted-by":"crossref","first-page":"26670","DOI":"10.18632\/oncotarget.8476","volume":"7","author":"XF Zhang","year":"2016","unstructured":"Zhang XF, Pan K, Weng DS, Chen CL, Wang QJ, Zhao JJ, Pan QZ, Liu Q, Jiang SS, Li YQ, Zhang HX, Xia JC. Cytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis. Oncotarget. 2016;7:26670\u20139.","journal-title":"Oncotarget"},{"key":"2082_CR9","first-page":"521","volume":"25","author":"I Schwartz","year":"1994","unstructured":"Schwartz I, L\u00e9vy D. Pathobiology of bovine leukemia virus. Vet Res. 1994;25:521\u201336.","journal-title":"Vet Res"},{"key":"2082_CR10","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1128\/JVI.70.4.2178-2183.1996","volume":"70","author":"ML Mirsky","year":"1996","unstructured":"Mirsky ML, Olmstead CA, Da Y, Lewin HA. The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection. J Virol. 1996;70:2178\u201383.","journal-title":"J Virol"},{"key":"2082_CR11","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/1348-0421.12073","volume":"57","author":"S Suzuki","year":"2013","unstructured":"Suzuki S, Konnai S, Okagawa T, Ikebuchi R, Shirai T, Sunden Y, Mingala CN, Murata S, Ohashi K. Expression analysis of Foxp3 in T-cells from bovine leukemia virus infected cattle. Microbiol Immunol. 2013;57:600\u20134.","journal-title":"Microbiol Immunol"},{"key":"2082_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/iid3.93","volume":"4","author":"K Ohira","year":"2016","unstructured":"Ohira K, Nakahara A, Konnai S, Okagawa T, Nishimori A, Maekawa N, Ikebuchi R, Kohara J, Murata S, Ohashi K. Bovine leukemia virus reduces anti-viral cytokine activities and NK cytotoxicity by inducing TGF-\u03b2 secretion from regulatory T cells. Immun Inflamm Dis. 2016;4:52\u201363.","journal-title":"Immun Inflamm Dis"},{"key":"2082_CR13","first-page":"291","volume":"54","author":"R Ikebuchi","year":"2010","unstructured":"Ikebuchi R, Konnai S, Sunden Y, Onuma M, Ohashi K. Molecular cloning and expression analysis of bovine programmed death-1. Microbiol Immunol. 2010;54:291\u20138.","journal-title":"Microbiol Immunol"},{"key":"2082_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1297-9716-42-103","volume":"42","author":"R Ikebuchi","year":"2011","unstructured":"Ikebuchi R, Konnai S, Shirai T, Sunden Y, Murata S, Onuma M, Ohashi K. Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade. Vet Res. 2011;42:103.","journal-title":"Vet Res"},{"key":"2082_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.vetimm.2011.08.018","volume":"144","author":"T Shirai","year":"2011","unstructured":"Shirai T, Konnai S, Ikebuchi R, Okagawa T, Suzuki S, Sunden Y, Onuma M, Murata S, Ohashi K. Molecular cloning of bovine lymphocyte activation gene-3 and its expression characteristics in bovine leukemia virus-infected cattle. Vet Immunol Immunopathol. 2011;144:462\u20137.","journal-title":"Vet Immunol Immunopathol"},{"key":"2082_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.vetimm.2014.10.006","volume":"163","author":"S Suzuki","year":"2015","unstructured":"Suzuki S, Konnai S, Okagawa T, Ikebuchi R, Nishimori A, Kohara J, Mingala CN, Murata S, Ohashi K. Increased expression of the regulatory T cell-associated marker CTLA-4 in bovine leukemia virus infection. Vet Immunol Immunopathol. 2015;163:115\u201324.","journal-title":"Vet Immunol Immunopathol"},{"key":"2082_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/intimm\/dxu076","volume":"27","author":"CU Blank","year":"2015","unstructured":"Blank CU, Enk A. Therapeutic use of anti-CTLA-4 antibodies. Int Immunol. 2015;27:3\u201310.","journal-title":"Int Immunol"},{"key":"2082_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3109\/14397595.2015.1109578","volume":"26","author":"T Mochizuki","year":"2016","unstructured":"Mochizuki T, Yano K, Ikari K, Hiroshima R, Takaoka H, Kawakami K, Koenuma N, Shirahata T, Momohara S. The efficacy of abatacept in Japanese patients with rheumatoid arthritis: 104 weeks radiographic and clinical results in clinical practice. Mod Rheumatol. 2016;26:499\u2013506.","journal-title":"Mod Rheumatol"},{"key":"2082_CR19","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1146\/annurev.immunol.19.1.565","volume":"19","author":"CA Chambers","year":"2001","unstructured":"Chambers CA, Kuhns MS, Egen JG, Allison JP. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu Rev Immunol. 2001;19:565\u201394.","journal-title":"Annu Rev Immunol"},{"key":"2082_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S1074-7613(02)00362-X","volume":"17","author":"AV Collins","year":"2002","unstructured":"Collins AV, Brodie DW, Gilbert RJ, Iaboni A, Manso-Sancho R, Walse B, Stuart DI, van der Merwe PA, Davis SJ. The interaction properties of costimulatory molecules revisited. Immunity. 2002;17:201\u201310.","journal-title":"Immunity"},{"key":"2082_CR21","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/S1470-2045(16)30366-7","volume":"17","author":"FS Hodi","year":"2016","unstructured":"Hodi FS, Chesney J, Pavlick AC, Robert C, Grossmann KF, McDermott DF, Linette GP, Meyer N, Giguere JK, Agarwala SS, Shaheen M, Ernstoff MS, Minor DR, Salama AK, Taylor MH, Ott PA, Horak C, Gagnier P, Jiang J, Wolchok JD, Postow MA. Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial. Lancet Oncol. 2016;17:1558\u201368.","journal-title":"Lancet Oncol"},{"key":"2082_CR22","doi-asserted-by":"publisher","first-page":"e98415","DOI":"10.1371\/journal.pone.0098415","volume":"9","author":"N Maekawa","year":"2014","unstructured":"Maekawa N, Konnai S, Ikebuchi R, Okagawa T, Adachi M, Takagi S, Kagawa Y, Nakajima C, Suzuki Y, Murata S, Ohashi K. Expression of PD-L1 on canine tumor cells and enhancement of IFN-\u03b3 production from tumor-infiltrating cells by PD-L1 blockade. PLoS One. 2014;9:e98415.","journal-title":"PLoS One"},{"key":"2082_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13567-018-0543-9","volume":"49","author":"T Okagawa","year":"2018","unstructured":"Okagawa T, Konnai S, Nishimori A, Maekawa N, Goto S, Ikebuchi R, Kohara J, Suzuki Y, Yamada S, Kato Y, Murata S, Ohashi K. Cooperation of PD-1 and LAG-3 in the exhaustion of CD4+ and CD8+ T cells during bovine leukemia virus infection. Vet Res. 2018;49:50.","journal-title":"Vet Res"},{"key":"2082_CR24","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1099\/0022-1317-75-9-2223","volume":"75","author":"A Mager","year":"1994","unstructured":"Mager A, Masengo R, Mammerickx M, Letesson JJ. T cell proliferative response to bovine leukaemia virus (BLV): identification of T cell epitopes on the major core protein (p24) in BLV-infected cattle with normal haematological values. J Gen Virol. 1994;75:2223\u201331.","journal-title":"J Gen Virol"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-019-2082-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12917-019-2082-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-019-2082-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T23:50:01Z","timestamp":1721951401000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-019-2082-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,29]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2082"],"URL":"https:\/\/doi.org\/10.1186\/s12917-019-2082-7","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,29]]},"assertion":[{"value":"12 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures were conducted following approval from the local committee for animal studies according to the Hokkaido University (17\u20130024). Collection of blood samples from healthy (non-treated) and BLV-infected cattle are announced as simple general permission procedure for the use of blood samples for assays. Verbal informed consent was fully obtained from all animal owners.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"380"}}